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ABSTRACT 
 
Alex Gillone: Role of Novel Quorum sensing molecules (DKPs-Diketopiperazines) as activators 
of bacterial virulence and host response.  
(Under the direction of Steven Offenbacher) 
Objectives: The aim of this project was to establish the functional role of novel quorum 
sensing molecules (Diketopiperazines – DKPs) on activation of bacterial virulence properties 
and the potential effects on host cells as activators of the innate immune response. Methods: The 
effect of DKPs on the growth and virulence properties of the periodontal pathogen, 
Porphyromonas gingivalis (P.g.) A7436 strain was examined. Secondarily, the effect of DKPs 
on human monocyte (THP-1) viability, growth and cytokine production upon lipopolysaccharide 
(LPS) stimulation was determined. THP-1 cells were collected, counted and the cell lysate was 
evaluated for Interleukin 1β (IL-1β) mRNA expression. Results: Our results demonstrate that 
DKPs minimally affect the growth of P. g. DKP alone did not significantly alter THP-1 viability 
(p=0.20), indicating it was not toxic to the cells. However, analysis of the IL-1β mRNA 
expression indicates that DKP inhibited the inflammatory response of LPS-stimulated THP-1 
cells. Conclusions: We have confirmed that DKPs minimally affect the growth of P. g. and 
cyclo(Leu-Pro) appears to slow the replication of THP-1 cells. Cyclo(Leu-Pro) seems to inhibit 
the expression of IL-1β in THP-1 cells. 
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CHAPTER 1: REVIEW OF SYNERGISTETES, FRETIBACTERIUM FASTIDIOSUM, 
CYCLODIPEPTIDES AND PERIODONTITIS 
 
Introduction 
 
Over the last two years evidence has been quickly mounting to implicate Synergistetes in 
the pathogenesis and progression of periodontal disease. Synergistetes have been identified as 
components of the oral microbiome. Synergistetes is a recently identified bacterial phylum that 
comprises one of the 13 different phyla identified in the human microbiome database from the 
oral cavity 1. Synergistetes was once defined as a rare phylum in the oral biofilm based on 
analysis utilizing 16s rRNA, with only 0.1-2% frequency 2. However, estimations based on 
fluorescence in situ hybridization (FISH) have suggested that Synergistetes may account for as 
much as 3.2-11.3% of the microbiota within deep pockets 3. Synergistetes are now not only 
considered a dominant phylum in the subgingival plaque, but their direct contact with host 
immune cells demonstrated by FISH suggests an important role in host-biofilm interactions 4.  
This concept is further supported by the novel observation that Synergistetes species are strongly 
associated with the production of novel quorum sensing (QS) molecules that have become 
identified by state-of-the-art metabolomic analyses of saliva. These QS molecules are known to 
stimulate the expression of genes that enhance the virulence of periodontal pathogens. Two new 
QS molecules have been identified which have never been ascribed to the oral microbiome 5. 
These two molecules are diketopiperazines (DKPs), which are cyclic dipeptides: specifically, 
cyclo(Leu-Pro) and cyclo(Phe-Pro). These DKP molecules are putative QS signaling molecules 
  
 
2 
that activate bacteria and possibly eukaryotic cells and are known entities in marine, food 
(spoilage) and plant-associated microbiology 6-8. 
Synergistetes and Fretibacterium fastidiosum 
The Synergistetes are a phylogenetic cluster of Gram-negative anaerobes related to 
Synergistes jonesii, sufficiently distinct from all other phyla to be considered a distinct phylum 
or Division. They have been demonstrated in several environmental ecosystems: human, animal, 
terrestrial and ocean habitats 9. Synergistes jonesii was the first species belonging to this phylum 
that was isolated in 1992 10. It was found in culture from a goat rumen and was able to degrade 
the toxic compound, 3-hydroxy-4(IH)-pyridone, that is produced in the rumen from mimosine. 
Degradation of 3-hydroxy-4(IH)-pyridone by these ruminal microbes is critical for protection of 
animals from leucaena toxicity. The isolates showed not to ferment carbohydrates, but were able 
to use arginine and histidine as substrates for growth. The name Synergistes for the genus was 
chosen to highlight their role of co-workers with the animal 10. There is confusion in the 
literature about the name of this new phylum, in fact in 1998 11, the candidate phylum 
“Synergistes” was first described in a phylogenetic study upon the global diversity of bacteria. 
However, this name was illegitimate due to its prior use for a genus 10 and for this reason Jumas-
Bilak and colleagues in 2009 suggested the name “Synergistetes” 12. Furthermore, most oral 
Synergistetes phylotypes were originally assigned/misclassified to the Flexistipes or 
Deferribacteres groups (phylum Diferribacteres) and Selenomonas genus, 
Syntrophomonadaceae family (Firmicutes phylum) 12-17, but further phylogenetic re-analysis 
placed them in the Synergistetes group 12, 18. 
In the late 90s-early 2000s early Synergistetes 16S rDNA sequences were found in 
molecular inventories of petroleum reservoirs 19, 20, pollution removal anaerobic digestors 21-25, 
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termite hindguts 26, 27, pig intestinal tract 28, human subgingival ecosystems and dental caries 13-15, 
29. Godon et al. in 2005, explored the Synergistetes in 93 anaerobic environments (soils, 
digestors, 49 animal guts, feces and the human oral cavity – subgingival plaque). They showed 
that from 16S rDNA gene-targeted PCR assays, this group appeared to be present in 90% of the 
anaerobic microbial ecosystems analyzed and also that there was a strong link between 16S 
rDNA sequences and given ecosystems. Indeed, Synergistetes 16S rDNA sequences from animal 
sources (termites, guinea pigs, pigs, birds, subgingival plaque, etc.) formed clustered 
phylogenetic groups. Synergistetes groups were also associated either with anaerobic digestors 
and soils or with thermophilic conditions. Synergistetes sequences were not found in human 
feces. Their results showed the wide diversity of the Synergistetes division as well as the specific 
ecological niche of each 16S rDNA sequence. Although Synergistetes were present in the 
majority of anaerobic ecosystems, this group belonged to a rare category since their frequency 
was generally below 1%. They concluded that the function of Synergistetes in anaerobic 
ecosystems remains unknown. However, Synergistetes seem to be anaerobic amino-acid 
degraders, suggesting that they may be involved in the turnover of amino acids in natural 
anaerobic ecosystems 18. The results (presence in 90% of the anaerobic ecosystems) reported by 
Godon are likely to be overestimated since their group-specific primers cross-reacted with other 
taxa 9. Horz et al. in 2006, described the first characterized human isolates of the division 
Synergistetes. They searched the R. M. Alden human clinical culture collection (Santa Monica, 
Calif.) for Synergistetes. They reported five slow growing and biochemically inert clinical 
isolates cultured from peritoneal fluid and two isolates from soft-tissue infections (sacral wound 
and diabetic-foot) that together constitute three separate evolutionary lineages within the 
phylogenetic radiation of the division Synergistetes. One of these clusters was formed by the 
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peritoneal isolates and had an 85% similarity to Synergistes jonesii (cluster I). The isolates from 
soft-tissue infections, on the other hand, formed two distinct lineages moderately related to each 
other with a similarity of approximately 78% (cluster II). In addition, by using a newly designed 
16S rRNA gene-based PCR assay with intended target specificity for Synergistetes, they found 
that the dominant phylotype from a human fecal sample was nearly identical to that of the strains 
obtained from peritonitis. On the contrary, sequence types detected in periodontal pockets, from 
patients with chronic and aggressive periodontitis, formed a separate cluster (III), that shared a 
similarity of only 80% with the soft-tissue isolates. The proportion of Synergistetes relative to 
the total microbiota was only 0.04% in these oral samples. In conclusion, their findings 
suggested a high diversity of medically important Synergistetes clades, which apparently are 
unique to individual ecological niches in the human body, and a possible pathogenic role for 
these microorganisms 30.  
In a review Vartoukian and co-workers described Synergistetes as a widely distributed 
phylum in nature, found in the human mouth, human gut and soft tissue infections. Generally, 
they represent only a minor constituent of the bacterial community in each habitat. They also 
hypothesized that these microorganisms have evolved to adapt to each habitat, and therefore 
exhibit a wide range of physiological and biochemical characteristics, although all cultivable 
taxa so far studied have the ability to degrade amino acids. They speculated them to be present in 
polymicrobial infections where anaerobes predominate and free amino acids are available. From 
an ecological standpoint, they supposed that Synergistetes likely play an intermediate role in the 
consortia found in these infections, such as periodontal disease, using amino acids made 
available from the breakdown of proteins and peptides by other organisms and, in turn, providing 
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short-chain fatty acids and sulphate for terminal degraders such as the methanogens and 
sulphate-reducing bacteria 9. 
In 2007 Jumas-Bilak et al. reported Jonquetella anthropi as the first characterized species 
of this new phylum that has been isolated in man. This microorganism was described as an 
anaerobic, Gram-negative rod with fastidious growth recovered in cultures from a peritoneal 
fluid sample, wounds, cysts and abscesses 31.  In 2009 another group 32 isolated a new species, 
Pyramidobacter piscolens, from the human oral cavity (odontogenic abscess), that is closely 
related to Jonquetella anthropi. The genus Pyramidobacter comprises strains that are anaerobic, 
non-motile and asaccharolytic bacilli 32. The same year Jumas-Bilak and co-workers proposed 
that the genera Aminiphilus, Aminobacterium, Aminomonas, Anaerobaculum, Dethiosulfovibrio, 
Jonquetella, Synergistes, Thermanaerovibrio and Thermovirga should be assembled in the same 
high-level taxon, the phylum Synergistetes, on the basis of 16S rRNA gene phylogeny 12. 
Another genus, Cloacibacillus, belonging to the phylum Synergistetes, was derived from a 
municipal wastewater treatment plant and was described by Ganesan et al. in 2008 33.   
Grice et al. in 2009 reported the presence of Synergistetes on the normal human skin of 
the umbilicus 34.  Marchandin et al. in 2010 35 demonstrated for the first time, using a culture 
independent-approach, the presence of Jonquetella anthropi and Pyramidobacter piscolens in 
vaginal microflora. They also proposed a classification of Synergistetes into five deeply 
branched clades named SYN-A to SYN-E, with an analysis based on larger data compared to 
Horz et al. 30. Only the subgroups SYN-A and SYN-B contained clones and isolates of human 
origin while SYN-C, SYN-D and SYN-E contained environmental species and clones. They 
concluded that the detection of human Synergistetes at different sites, in independent studies 
under both pathological and physiological conditions, suggested that bacteria of this phylum 
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were not occasional contaminants, but that they are part of the commensal human microflora and 
may act as opportunistic pathogens 35. 
In 2015 Domingo et al. proposed Cloacibacillus  evryensis and Cloacibacillus porcorum 
as potential human pathogens associated with bacteremia 36. The same year Jumas-Bilak and co-
workers described Rarimicrobium hominis, a species belonging to the fifth genus in the phylum 
Synergistetes that includes human clinical isolates from gynecological material 37.   
Despite the habitat diversity that characterizes this phylum, isolates bear a physiological 
resemblance to one another in that they are all strictly anaerobic, neutrophilic Gram-negative 
rods or vibrios that ferment amino acids. In fact, Hugenholtz et al. in 2009 reported that 
Synergistetes have the highest average proportion of amino acid transport and metabolism genes 
of any bacterial phylum. They also reported that Synergistetes have the genes that are normally 
used for LPS biosynthesis but they appear to lack genes for the TolAQR-Pal complex that is 
responsible for assembly and maintenance of the outer membrane 38. Unfortunately, not many 
other common characteristics for all the species of this phylum are known. Bhandari et al. in 
2012, reported the identification of 32 conserved signature indels (CSIs), i.e. insertions/deletions 
in the DNA of these microorganisms, in widely distributed proteins such as DNA-directed RNA 
polymerase β subunit (RpoB), DNA-directed RNA polymerase β’ subunit (RpoC), UvrD/REP 
helicase (UvrD), DNA gyrase A subunit (GyrA), DNA polymerase I (PolA), DNA polymerase 
III α subunit (PolC), S-adenosylmethyltransferase MraW (MraW), Nicotinate nucleotide 
adenylyltransferase (NadD), Orotate phosphoribosyltransferase (PyrE), 30S ribosomal protein S1 
(RpsA), Ribosomal protein S8 (RpsH), Cell division protein FtsA (FtsA), DNA repair protein 
RadA (RadA), etc., including a large >300 amino acid insert within the RpoC, that are present in 
various Synergistetes species, but except for isolated bacteria, these CSIs are not found in the 
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protein homologues from any other organisms. As CSIs are present in most or all Synergistetes 
and absent in other taxonomic groups, they provide strong evidence that species of the 
Synergistetes phylum constitute a monophyletic group that is distinct from all other prokaryotic 
taxa. Among these CSIs, 22 are specifically present in Jonquetella and Pyramidobacter 
indicating a close association between these two species. Additionally, they demonstrated that 
several CSIs were commonly shared by Synergistetes and some species from other bacterial 
phyla suggesting potential cases of lateral gene transfers 39. 
Synergistetes are found in the human mouth where they appear to be more numerous in 
dental and gingival disease than health 2, 3, 9, 13, 40-42.  Human oral Synergistetes can be divided 
into two main groups 9: cluster B, which comprises Jonquetella anthropi 31 and Pyramidobacter 
piscolens 32, and cluster A, which comprises 22 other taxa (such as Fretibacterium fastidiosum) 
for which one cultivable representative is available 43, 44.  
Synergistetes are now not only considered a dominant phylum in the subgingival plaque, 
but their direct contact with host immune cells demonstrated by FISH suggests an important role 
in host-biofilm interactions 4. FISH analysis also revealed that uncultivable oral Synergistetes 
cells were large curved bacilli 3 that are significantly more abundant and have increased diversity 
in the subgingival plaque of patients with periodontal disease as compared to healthy patients 3, 45. 
In addition, only cluster A was detected in subgingival plaque samples, using FISH analysis, and 
Synergistetes OTU 4.2 was found in significantly more subjects with periodontitis than controls 
and was more abundant in subgingival plaque at diseased sites than at healthy sites in subjects 
with periodontitis or healthy controls 3. Park and colleagues demonstrated the presence of 4 
dominant phyla, in a human periodontitis population from Korea, including Bacteroidetes, 
Fusobacteria, Synergistetes, and Spirochaetes 46. Similarly a previous report has shown that 
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Spirochaetes, Synergistetes, and Bacteroidetes were identified as the dominant phyla in 
periodontitis patients 47. More importantly, using HOMIM methods, patients with refractory 
periodontitis  (based on mean attachment loss (AL) and/or >3 sites with AL ≥2.5 mm after SRP, 
surgery and systemically administered amoxicillin and metronidazole (within one year post-
therapy) have been distinguished from those with treatable severe periodontitis and healthy 
patients by significantly higher frequency of specific pathogens, including Synergistes species 
cluster II, that belong to the Synergistetes phylum, in subgingival plaque 48. 
Baumgartner et al. 2012 49, in a Chinese population, demonstrated that Synergistetes 
cluster A bacteria, but not cluster B bacteria or Jonquetella anthropi, are more strongly 
associated with Necrotizing Ulcerative Gingivitis (NUG) than with gingivitis (9.4 fold higher 
numbers). Therefore, the mounting evidence points to the central importance of Synergistetes as 
an important phylum in the context of periodontal disease and in poor treatment outcomes.  
Synergistetes cluster A, but not cluster B, bacteria were found at higher prevalence, numbers and 
proportions in saliva from patients with periodontitis (generalized aggressive and chronic 
periodontitis), than non-periodontitis subjects in a Turkish population. The proportion of 
Synergistetes cluster A tended to be higher in generalized aggressive periodontitis patients than 
chronic periodontitis patients 50. Moreover, a positive correlation was revealed between the 
levels of Synergistetes cluster A and all clinical measurements, including probing pocket depth, 
clinical attachment loss, plaque index and bleeding on probing scores. Accordingly, a recent 
study demonstrated that subgingival plaque from Chinese patients with periodontitis exhibits 
higher numbers and more diverse operational taxonomic units of Synergistetes cluster A, 
compared to periodontitis-free subjects 45. The low prevalence and levels of Synergistetes cluster 
B, including Jonquetella anthropi, in all these studies may indicate that these taxa may not have 
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a crucial etiological role in periodontal diseases 49, 50. In periodontitis patients Marchesan et al. in 
2015 showed that the microbial community comprising Synergistetes was highly associated with 
clinical parameters for periodontitis (high probing depth and high bleeding on probing); they also 
hypothesized that since Synergistetes were associated with trans-4-hydroxyproline, a marker of 
collagen metabolism, these microorganisms could be associated in the destruction of soft tissue 
and bone 5.  
Conversely to the above-mentioned studies Yu et al. failed to show that Synergistetes are 
more abundant and more readily detected within periodontitis and peri-implantitis lesions 
compared to healthy peri-implant and periodontal sites in a Chinese population. They were 
unable to establish concrete differences/similarities between Synergistetes communities present 
within diseased sites compared to healthy sites; or between periodontal/subgingival niches 
compared to peri-implant/sub-mucosal niches. Taken together, their results suggest a more 
nuanced relationship between Synergistetes taxa and polymicrobial infectious diseases of the 
periodontium 51.  One of the reasons this study did not found differences could that this 
population comprised only patient with a history of periodontitis and considered healthy and 
diseased sites within the same patient, so colonization of the healthy sites could not be excluded. 
Accordingly, da Silva et al. in 2014, using a Sanger sequencing-based approach, found higher 
levels of Synergistetes taxa within healthy implant sites compared to peri-implantitis sites 52. 
Another group, Belibasakis et al., used FISH probes specific for Synergistetes cluster A and B 
cells and epifluorescence microscopy, to study their distributions within biofilms sampled from 
healthy and diseased peri-implant sites. They noted that the prevalence and numbers of 
Synergistetes cluster A were significantly higher within diseased peri-implant niches compared 
to non-diseased sites. Moreover, the levels of Synergistetes cluster A in biofilms significantly 
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correlated not only with probing pocket depth, but also with bone loss, suppuration, and bleeding 
on probing, potentially indicating their stronger association with the severity of peri-implantitis 
than Spirochetes 53. In conclusion there has been an association of Synergistetes with peri-
implantitis 54, but it is still less well established than with periodontitis.  
Besides periodontal and peri-implant disease, the presence of Synergistetes has been 
demonstrated in man during endodontic infections and in dental caries 14, 55-58.  Siqueira and 
Rôças in 2007, using a 16S rRNA gene-based group-specific heminested PCR protocol, 
demonstrated that Synergistetes phylotypes are present in the microbiota from primary 
endodontic infections and suggested a possible role in causation of apical periodontitis. 
Considering that virtually all cultivated Synergistetes strains degrade amino acids in anaerobic 
ecosystems, these bacteria may be favored by the environmental conditions in necrotic root 
canals. The oral clones W028, BA121/P4G_18 P1, W090, BH017 and E3_33 were found in 
endodontic infection 55. The same Brazilian group found Synergistetes also in cases of persistent 
endodontic infections (root-filled teeth) associated with asymptomatic chronic periradicular 
lesions 56. Vianna et al. showed that the quantity of Synergistetes in primary endodontic 
infections with radiographic evidence of apical periodontitis was clearly within the range of the 
other analyzed pathogens (Prevotella intermedia, Porphyromonas gingivalis, Treponema), 
suggesting their clinical relevance in endodontic infections 59. In 2014 do Cabo Fernandes et al., 
through FISH analysis, showed the presence of Synergistetes cluster A in the apical tissue fluid 
of both an apical periodontitis and previously root-filled with apical periodontitis group of 
patients, but not in the irreversible pulpitis group. Synergistetes cluster B was not detected in any 
of the groups. They concluded that Synergistetes cluster A may be involved in the pathogenesis 
of apical periodontitis 60.  
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Fretibacterium fastidiosum (or strain SGP1T) has been identified as a key periodontal 
disease-associated species 5. Park and colleagues, through pyrosequencing analysis of 
subgingival microbiota associated with distinct periodontal conditions in a Korean population, 
found that F. fastidiosum, Fretibacterium genus and other unclassified Synergistetes are highly 
increased in periodontitis subjects. Among the taxa assigned by Abusleme to the “core” 
periodontitis-associated microbiome Fretibacterium fastidiosum and other Fretibacterium 
species were also included 52. Furthermore, You and colleagues showed that Fretibacterium 
fastidiosum is more prevalent in subgingival plaque samples from patient with periodontitis than 
periodontitis-free controls 45.  Lourenço et al., in 2014, using HOMIM, noted that absence of 
Fretibacterium spp., Fusobacterium naviforme/Fusobacterium nucleatum ss vincentii and 
Granulicatella adiacens/ Granulicatella elegans was associated with a higher risk for aggressive 
periodontitis in relation to chronic periodontitis 61. This finding will need to be confirmed in the 
future with other studies.  Fretibacterium fastidiosum is not only associated only with 
periodontal disease, in fact it was found both before and after chemo-mechanical preparation of 
the root canals of teeth with endodontic-periodontal lesions 62 as well as of single-rooted teeth 
with apical periodontitis 63.	 
Although Synergistetes have been traditionally classified as non-cultivable, Vartoukian 
and colleagues in 2010 were able to cultivate this new strain after isolation from the human 
subgingival plaque of a deep periodontal pocket by means of colony-hybridization-directed 
enrichment and co-culture with other oral bacteria 43. 
The name Fretibacterium fastidiosum was given to underline both the dependence of this 
organism on co-culture for good growth and its nutritional requirements. Indeed, for good 
growth the strain SGP1T or Frectibacterium fastidiosum was dependent on co-culture with, or 
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extracts from, selected other oral bacteria (such as Fusobacterium nucleatum). Independent 
culture of SGP1T on blood agar resulted in a varying amount of growth, ranging from no growth 
to a biomass equivalent to approximately a quarter of that resulting from co-culture with the 
feeder strain 44. More recent studies from the same group confirmed these results, implying a 
possible dependence of this species on helper strains to form a viable biofilm. The relationship 
between helper and recipient strain could be the result of a dependence on the helper for the 
provision of specific chemical factors, such as siderophores, because they have lost the ability to 
produce them 64.    
SGP1T cells were described as obligate anaerobic, motile, Gram-negative, curved bacilli 
and asaccharolytic. Their size was 1.0–1.56 µm in width and 2.0–13.0 µm in length or elongated 
in older cultures 44. Ultrastructural analysis using transmission electron microscopy showed a 
distinctive internal structure comprising micro-compartment organelles 43. After 21 days 
incubation on blood agar plates streaked with Fusobacterium nucleatum, colonies were 
approximately 0.5 mm in diameter with a circular, high convex central, smooth, off-white, 
opaque central region surrounded by a highly irregular, semi-translucent periphery, though some 
variations were also observed. After 3 months and numerous subcultures a second and distinct 
colonial morphology bigger in size (1.3 mm in diameter) and phenotypically different was 
observed. The optimal growth temperature was 37 °C (with minimal growth at 25 °C and 42 °C) 
and optimal pH of 6-7. Major amounts of acetic acid and moderate amounts of propionic acid 
were produced as end products of metabolism in peptone-yeast extract-glucose broth 
supplemented with a filtered cell sonicate of Fusobacterium nucleatum. Hydrogen sulphide was 
produced and gelatin was weakly hydrolyzed. Enzyme profiles generated with the Rapid ID 32A 
panel tests gave positive results for leucyl glycine arylamidase and glycine arylamidase. Nitrate 
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was not reduced and neither catalase nor indole were produced. A predominance of myristic, 
palmitic and stearic cellular fatty acids was found. Antibiotic susceptibility included amoxicillin, 
ampicillin, metronidazole and penicillin; the colonies were moderately susceptible to 
erythromycin; and resistant to ciprofloxacin and other antibiotics 44.  
Cyclodipeptides 
Cyclodipeptides [also known as 2,5-diketopiperazines; 2,5 dioxopiperazines; cyclic 
dipeptides; or dipeptide anhydrides] are among the simplest naturally occurring peptide 
derivatives 65. They are considered relatively stable and inert molecules with a peculiar 
heterocyclic, chiral, rigid and functionalized structure that responsible for their unique biological 
properties 65-67. They are derived from the head-to-tail cyclization of two linear α amino acids to 
form a lactam 6. In fact, these compounds show a common scaffold, easily obtained by standard 
synthesis procedures, that favors structural diversity as a function of substituent side chains 
particularly oriented. Favorable pharmacodynamic and pharmacokinetic characteristics are 
acquired by the compounds through these properties 66. In addition, the core scaffold of DKPs 
makes these molecules resistant to proteolysis and enables them to cross the intestinal wall and 
even the blood–brain barrier 68. Generally, biosynthesis of cyclodipeptides can be achieved in 
three different ways. The first one is by a dedicated nonribosomal peptide synthetase (NRPS), a 
multimodular enzyme complex; an alternative second route that also uses NRPS but produces 
truncated side products during the synthesis of larger peptides, or by a novel type of synthetases 
named cyclopeptide synthases that use aminoacyl-tRNAs 69, 70. 
The first cyclic dipeptide, cyclo(Gly-Gly), was synthesized in 1888 by Curtius and 
Gloebel 71. The focus on this group of compounds in nature started between the late 1800s and 
early 1900s, when many simple diketopiperazines such as cyclo(Gly-Gly) were synthesized in 
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order to examine their interesting physicochemical properties and biological roles 65. Another 
early report comes from Abderhaden and Komm in 1924 72. Recently these compounds attracted 
attention due to their various therapeutic possibilities 66.  
Most cyclopeptides are isolated from natural sources, as secondary functional metabolites 
or side products of terminal peptide cleavage, but because of their structural simplicity they also 
could be easily synthetized 66. In later years, some of the cyclic dipeptides have emerged as by-
products of food processing under certain chemical, thermal and storage conditions. They also 
have been derived from proteins, polypeptide hydrolysates, fermentation broths and cultures of 
yeast, lichens, and fungi 65.  Many cyclic dipeptides are endogenous to members of animal and 
plant kingdoms; these include cyclo(Pro-Leu), cyclo(Pro-Val), cyclo(Pro-Phe), cyclo(Ala-Leu), 
cyclo(Pro-Tyr), cyclo(Pro-Trp), cyclo(Pro-Gly) and cyclo(His-Pro) 65, 68.  
A well-defined group of DPKs are those that derive from marine organisms. In the 
review from 2010 by Huang et al., a total of 124 DKPs molecules where described, covering the 
literature up to December 2008. They reported that some of these compounds have been found to 
possess various bioactivities including cytotoxicity, antibacterial, antifungal, antifouling, plant-
growth regulatory, and other activities. They also described the marine sources and distribution 
of these molecules, 76% from marine microorganisms, 19% from sponges, 1% from sea stars 
and tunicates (ascidians) and 3% from red algae 69. The same group in 2014 published an update 
on the ninety 2,5-diketopiperazines from marine organisms, reported from 2009 to the first half-
year of 2014 6.  
Although the six cyclic dipeptides-cyclo(His-Pro), cyclo(Leu-Gly), cyclo(Tyr-Arg), 
cyclo(Asp-Pro), cyclo(Pro-Phe) and cyclo(Pro-Gly) exhibit interesting physiological and/or 
pharmacological activities in mammals, only two of these, cyclo(His-Pro) and cyclo(Pro-Gly), to 
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the best of our knowledge, have been shown to be endogenous to mammals. On the contrary, 
cyclo(Leu-Gly), cyclo(Tyr-Arg), and cyclo(Asp-Pro) are structurally related to endogenous 
peptides Pro-Leu-Gly-NHs (melanocyte-stimulating hormone release inhibiting factor), Tyr-Arg 
(kyotorphin), and Val-Pro-Asp-Pro-Arg (enterostatin), respectively, which may serve as 
precursor peptides 65, 73. 
Cyclo(His-Pro), due to its structural similarity, has been regarded as having a precursor-
product relationship with thyrotropin-releasing hormone (TRH) 65, 66, 68. Cyclo(His-Pro) has been 
found in various human fluid compartments, such as central nervous system (CNS), pancreas, 
milk, blood, cerebrospinal fluid, semen, urine and amniotic fluid. In the CNS, Cyclo (His-Pro) 
appears to modify the sedative effects of ethanol (through mediation of the GABA ionotropic 
receptor), ketamine and pentobarbital, and also to play an important role in the perception of pain 
stimuli, hypothermia and anorectic effects 65, 66. Moreover it was described to have antioxidant 
and TRH-regulatory activities 66, 67 and to exert an anti-inflammatory effect in vivo in the CNS 
by counteracting LPS-induced reactive gliosis 74. 
Diketopiperazines have been proposed as a new family of signaling compounds, used in 
QS 66, 75, 76, that is a mechanism of cell-to-cell communication via secreted small molecules, used 
by bacteria 68. Furthermore, several reports have prompted the proposal that DKP could represent 
a new class of QS signals and potentially even interspecies and interkingdom signals 65, 76-78. 
Some studies reported that DKPs from a range of Gram-negative bacteria were able to modulate 
LuxR, TraR, or LasR activity in AHL-sensitive biosensor strains, in which the LuxR-type 
proteins are overproduced, previously considered specific for N-acyl homoserine lactones (AHL) 
79-82. Campbell et al. 2009 challenged this concept and failed to demonstrate the same results and 
a direct interaction with LuxR-type proteins 79.  
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In general, many DKPs show interesting biological activities such as: alteration of 
cardiovascular (heart rate, cardiac output) and blood-clotting functions, antiviral (e.g., the 
gliotoxins and sporidesmins), phytotoxic [e.g., cyclo(Pro-Tyr)], antibacterial (e.g., 
bicyclomycin), antifungal, antiprion, antiprotozoal, antitumor and antihyperglycemic properties, 
inhibition of glycosidase, inhibition of plasminogen activator inhibitor-1, inhibition against 
aflatoxin production, affinities for calcium channels, opioid, GABAnergic, serotoninergic 5-
HT1A and oxytocin receptors 65, 66, 70.  
Semon in 2010 hypothesized that cyclodipeptides from food (such as malt, cocoa and 
beer) and intestinal yeast cyclodipeptides synthetized by Candida albicans may play a role, 
throughout fetal development and postnatal development, in causing psychiatric disorders. This 
hypothesis is based on cancer research, where cyclic dipeptides such as cyclo(Pro-Phe) have 
been found to activate the pathways of apoptosis and to cause programmed cell death. Activation 
of such pathways is also thought to be central in causing the neurodevelopmental abnormalities 
seen in disorders such as schizophrenia, autistic disorder, and perhaps Alzheimer’s disease 83. 
Conversely Bellezza et al. in 2014 argue that, because of its capacity to regulate inflammation 
via glial cells and induce a protective response in neuronal cells, cyclo(His-Pro) has potential 
therapeutic utility in an array of neuroinflammatory diseases 68. 
According to the literature and within the limits of the available investigations, we 
hypothesize that DKPs could act as QS molecules in the oral biofilm inhibiting P.g. growth 
and gingipain production as well as modify cytokine production by THP-1 cells.  
  One of the basic science goals of this study is to try to understand the role of these 
molecules in oral biology. Unraveling the pathways of cell-to-cell and cell-to-host 
communication could lead to improved knowledge of the oral biofilm and its difference from 
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other ecosystems. In addition, understanding their mechanism of action may lead to new 
treatment modalities. 
Statements of purpose, hypothesis and specific Aims: 
The role of these cyclo dipeptides in the oral ecosystem has not been explored. Previous 
studies, from other ecosystems, define them as QS molecules. We seek to establish the functional 
role of these molecules on activation of bacterial virulence properties and the potential effects on 
host cells. Two specific aims are developed to test our hypothesis that these molecules act as QS 
molecules within the oral biofilm. 
Aim 1: To assess the role of DKPs on the growth of periodontal pathogens and on the 
expression of virulence genes of key pathogens (e.g., P. g. expression of gingipain).  
 
We will grow P.g. strain A7436 and we will treat it with different concentrations of 
DKPs. Growth curves will be recorded and analyzed. Supernatant will be collected at the early 
stationary phase in order to assess gingipain activity through the use of a colorimetric assay.  
Aim 2: Measure the effect of DKPs on the LPS-mediated inflammatory cytokine response 
in a human monocytic cell line (THP-1). 
 
We will growth THP-1 monocytic cells and we will challenge them with varied 
concentrations of LPS 84, 85 and DKPs in order to assess the effect on cell viability after 24 hours. 
The cell lysate will be collected and IL-1β production will be assessed through qRT-PCR.    
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CHAPTER 2: ROLE OF NOVEL QUORUM SENSING MOLECULES (DKPS-
DIKETOPIPERAZINES) AS ACTIVATORS OF BACTERIAL VIRULENCE AND 
HOST RESPONSE 
Introduction 
Over the last few years evidence has been mounting quickly to implicate Synergistetes in 
the pathogenesis and progression of periodontal disease 1. Synergistetes have been identified as 
components of the oral microbiome. Synergistetes is a recently identified bacterial phylum that 
represents one of the 13 different phyla identified in the human oral microbiome database from 
the oral cavity 2. Synergistetes was once defined as a rare phylum in the oral biofilm based on 
analysis utilizing 16s rRNA, with only 0.1-2% frequency 3. However, estimations based on FISH 
have suggested that Synergistetes may account for as much as 3.2-11.3% of the microbiota 
within deep pockets 4. Synergistetes are now not only considered an important phylum in the 
subgingival plaque, but their direct contact with host immune cells demonstrated by FISH 
suggests an important role in host-biofilm interactions 5.  This concept is further supported by the 
novel observation that Synergistetes species are strongly associated with the production of novel 
QS molecules that have become identified by state-of-the-art metabolomic analyses of saliva. 
These QS molecules are known to enhance the overall expression of genes that enhance the 
virulence of pathogenic bacteria. Precisely, two new QS molecules have been identified, which 
have been ascribed only recently to the oral microbiome. These two molecules are DKPs which 
are cyclic dipeptides: specifically, cyclo(Leu-Pro) and cyclo(Phe-Pro) 6.  Not long ago, another 
metabolomic cohort study of HIV infected patients reported the presence of cyclo(Leu-Pro) in 
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the oral metabolome of the healthy control group (uninfected patients). This metabolite was 
shown to be paired with Fusobacteriaceae Fusobacterium 7. 
These DKP molecules are putative QS signaling molecules that activate bacteria and 
possibly eukaryotic cells and are known entities in marine biology 8, 9, food (spoilage) 
microbiology and likely bacteria swarming 10-12. Fuqua and Winans introduced the term QS to 
describe a cell-to-cell communication signaling pathway, based on population density, used by 
bacteria to detect changes in their environment and consequently to apply specific strategies that 
allow adaptation to environmental stress in space and time 13. This mechanism is regulated by 
small, diffusible signal molecules known as autoinducers, and their associated protein receptors 
14-17. There are two main groups of signal molecules involved in bacterial QS; one is the peptide 
derivatives typically used by Gram-positive bacteria, while fatty acid derivatives are exploited by 
the Gram-negative bacteria 10. Quorum sensing in Gram-negative bacteria was first characterized 
in Vibrio fischeri, a luminous symbiotic species that provides its marine eukaryotic host with 
light, and is under the control of AHL signals and the LuxR-type family of cytoplasmic receptors 
14, 17-21. The AHL ligands are most frequently generated by LuxI-type synthases, and their local 
concentration correlates with cell density and other environmental factors 14. Above a threshold 
level (i.e., the quorum level) the AHLs bind to the LuxR-type receptors and activate the 
transcription/expression of target genes required for bacterial adaptation. The functional 
behaviors influenced by this cell-to-cell signaling include biofilm/extracellular matrix formation, 
bioluminescence, conjugation, pigment production, sporulation, secretion of virulence factors, 
adaptation/survival in hostile environments, etc. 10, 22. Considering that many of these pathways 
play central roles in both pathogenesis, symbiosis and host-bacteria communication, there is 
substantial interest in the development of ligands that can block or mimic native autoinducer 
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signals to attenuate QS and thus can be used as novel therapeutic strategies for the control of the 
human microbiome 14, 21, 23, 24.  Certain 2,5-diketopiperazines have been isolated from bacteria 
and reported to activate or inhibit LuxR-type proteins 25-27.  
Porphyromonas gingivalis is a recognized periodontal pathogen and is described as 
belonging to the red complex, a group of bacteria associated with severe forms of periodontal 
disease 28. Moreover, significant negative correlations were found, in a study on primary 
endodontic infections, between Synergistetes and P. gingivalis. Since both species have a 
proteolytic capacity, and because the small amount of available carbohydrates in an infected root 
canal is quickly depleted, substrate (i.e. proteins) competition among these groups might be the 
most plausible reason 29.  For all these reasons we decided to study the effect of DKPs on P. 
gingivalis growth and virulence factor production. Virulence factors are molecules expressed and 
secreted by pathogens (bacteria, viruses, fungi, and protozoa) that enable them to replicate and 
disseminate within a host in part by subverting or eluding host defenses 21. Gene expression of 
tpr proteases (thiol protease), a known virulence factor of P. gingivalis, has been shown to be 
regulated by peptide nutrients in vitro. Addition of the dipeptide phenylalanyl-phenylalanine to 
the growth medium resulted in a 10-fold decrease in tpr expression, underlying the importance of 
phenylalanine-containing peptides as a controlling factor 30. Gingipain proteases are the major 
virulence factor produced by the periodontopathogenic bacterium P. gingivalis and thus will be 
the focus of our study 31.  
Macrophages are major sources of many cytokines (TNFs, interleukins, chemokines) that 
are involved in immune response, inflammation, hematopoiesis and many other homeostatic 
processes 32. Upon stimulation/binding by micro-organisms, exogenous molecules, or 
endogenous factors including cytokines; macrophages can synthesize de novo and release, within 
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a few hours, a large variety of cytokines, such as IL-1, IL-6, IL-8, IL-10, IL-12, TNF-α, IFN-α, 
IFN-γ, MCP-1, MCP-3, MIF, M-CSF et al. 33. Macrophages, central cells of the innate immune 
system, recognize invasive microbial pathogens and for this reason are of paramount importance 
in periodontal disease 34. Monocytic cell lines, such as THP-1 cells, have been shown to produce 
several cytokines in response to stimulation by LPS, either from E.coli and P.gingivalis 35, 36.  In 
mammals, DKPs such as Cyclo(Hys-Pro) have been shown to act on glial cells, the resident 
macrophages of the CNS, to control a conceptually homologous behavioral switch between 
homeostatic and inflammatory modes, as well as inducing a protective state in neuronal cells, 
with implications for the control of neurodegenerative disease 21. Considering this action of 
DKPs on macrophage cells in the CNS and since Synergistetes were found in close contact with 
immune system cells in the oral biofilm 5, we are interested in exploring the effect of these 
molecules on monocytic cells.   
Thus, in this study we are aiming to establish the functional role of these novel QS 
molecules on activation of bacterial virulence properties and their potential effects on host cells. 
Firstly, we assessed the role of DKPs on growth of a specific periodontal pathogen, P. gingivalis 
and on its expression of virulence genes (gingipain). Secondly, we measured the effect of DKPs 
on the LPS-mediated inflammatory cytokine response in a human monocytic cell line (THP-1).  
Materials and Methods 
Porphyromonas gingivalis experiments 
Periodontal pathogen P. gingivalis A7436 was cultivated in Wilkins-Chalgren (WC) 
broth (Oxoid LTD, Basingstoke, Hampshire, England) under anaerobic conditions at 37ºC. P.  
gingivalis strain A7436 was incubated with variable concentrations of cyclo(Leu-Pro) and 
cyclo(Phe-Pro) (Bachem AG, Bubendorf Switzerland) for 26 hours (late exponential phase).  The 
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DKP concentrations were 1000 ng/ml, 100 ng/ml and 10 ng/ml for both cyclopeptides. 
Cyclo(Leu-Pro) and cyclo(Phe-Pro) were initially dissolved in methanol (Fisher Scientific,	Fair 
Lawn, New Jersey) (50 mg/ml in MeOH), following the company instructions. A final 
concentration of 0.002% MeOH was reached for each cyclopeptide.  Porphyromonas gingivalis 
not treated with cyclopeptides and treated with the vehicle alone (0.002% MeOH) were used as 
negative controls. The OD was assessed with the use of a spectrophotometer equipped with 
cuvette port reader (Spectra Max M2, Molecular Devices, Sunnyvale, CA), at a wavelength (λ) 
of 660nm at different time points (0, 16, 23, 26 hours) until the stationary phase was reached. 
During the early stationary phase 1 ml of supernatant was collected from each sample and was 
stored at -80ºC in order to evaluate gingipain activity.   
The activity of the two cyclopeptides against on bacterial gingipain production was 
evaluated by a Trypsin colorimetric assay (Abcam, ab102531, Cambridge, MA, USA) using a 
synthetic substrate and the supernatant collected from the samples. In Abcam’s Trypsin Activity 
Assay Kit (Colorimetric), trypsin cleaves a substrate to generate p-nitroaniline (p-NA) which is 
detected at λ=405 nm. The substrates were dispensed into the wells of a 96-well microtiter plate. 
Fifty microliters of bacterial supernatant from each sample were added to the substrate and 
incubated at 25ºC for 4 hours. Using the 2mM p-NA standard, a standard curve dilution was 
prepared. Adsorption at a wavelength of 405 nm was determined by the microtiter plate reader 
(Spectra Max M2) at 0, and 4 hours. Background was corrected by subtracting the value derived 
from the zero trypsin standard from all sample readings. The concentration of p-NA in nmol was 
calculated comparing the 405 nm readings for each sample to the standard curve.  
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THP-1 Experiment 
Human monocytic cells, THP-1[THP-1] (ATTC® TIB-202tm) were cultivated in RPMI-
1640 (ATTC® 30-2001tm) with 10% fetal bovine serum (Sigma-Aldrich, Saint Louis, MO, 
USA), and 0.05mM Beta Mercaptoethanol (Sigma-Aldrich) at 5% CO2 and 37°C. 500,000 cells 
were plated in each well, and were treated for 24 hours with a combination of different 
concentrations of LPS (0, 300 and 3000 ng/mL) from E. coli 0111:B4 (cat # L2630, Sigma-
Aldrich Co) and cyclo(Leu-Pro) (0, 10, 100 ng/ml) (Bachem AG, Bubendorf. Switzerland).  
Cells were collected and counted with an automated cell counter (CellometerTM AutoT4, 
Nexcelom Bioscience LLC, Lawrence, MA, USA) and cell lysate was evaluated for IL-1β 
mRNA expression, with results normalized to housekeeping GAPDH. 
RNA isolation and quality control 
Cells were lysed with RIPA buffer (R0278 from Sigma-Aldrich) and homegenized with a 
QIAshredder homogenizer (Qiagen, Valencia, CA, USA). RNA was isolated from cell lysate 
using RNeasy Mini kit (Qiagen) according to the manufacturer's instructions. The RNA was 
quantified using the NanoDrop ND-1000 spectrophotometer (Nanodrop Technology, 
Montchanin, DE, USA).  
Quantitative Real-time PCR and IL-1β expression analysis 
For each sample, a volume of 500 ng of RNA in a total volume of 20ul was used to 
generate complementary DNA (cDNA) through reverse transcription reactions using the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, now ThermoFisher Scientific 
USA). Quantitative real-time PCR (qRT-PCR) was performed with 1.25µL of synthesized 
cDNA, 7.5µL of Taqman® Universal PCR Master Mix, 0.75µL of Taqman® Gene Expression 
Assay Mix for IL-1β gene and 5.5µL of dH2O using StepOnePlus Real Time PCR system 
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(Applied Biosystems). The mRNA expression levels were normalized using GAPDH as the 
housekeeping gene.  
Statistics The	data	analysis	 for	 this	paper	was	generated	using	SAS	9.4	 software.	Copyright,	SAS	 Institute	 Inc.	 SAS	 and	 all	 other	 SAS	 Institute	 Inc.	 product	 or	 service	 names	 are	registered	 trademarks	 or	 trademarks	 of	 SAS	 Institute	 Inc.,	 Cary,	 NC,	 USA.	 Statistical	significance	was	set	at	p<0.05.			Mean	and	standard	errors	were	determined	to	describe	the	data.	 	ANOVA	and	ANCOVA	modeling	were	performed	using	SAS	Proc	GLM	to	calculate	p-values.	ANCOVA	was	used	to	assess	P.	gingivalis	growth	curves	at	different	time	points	as	well	 as	 trypsin-like	 activity.	 	 ANOVA	 was	 utilized	 to	 evaluate	 THP-1	 cell	 viability	 and	number	 of	 cells/ml,	 after	 logarithmic	 transformation,	 since	 the	 baseline	 number	 of	 cells	(500000	cells	per	well)	was	equal	in	each	group.	ANOVA	was	used	to	study	IL-β	mRNA	fold	change	(IL-β/GAPDH).		
Results 
Porphyromonas gingivalis growth curves 
 Our results demonstrate that both DKPs can minimally decrease the growth of P. 
gingivalis, with cyclo(Leu-Pro) having a slightly higher inhibitory effect when compared to 
cyclo(Phe-Pro) (Figures 1-2). The difference, in growth of P. gingivalis, between the vehicle and 
cyclo(Leu-Pro) at 1000 ng/ml and 10 ng/ml was statistically significant at 26 hours, with higher 
inhibition in the test groups (ANCOVA testing each timepoint adjusting for baseline and 
concentration, p≤0.05). The biological significance of this finding could be limited. The presence 
at the experimental concentrations of both DKPs seemed not to have a significant effect on the 
growth of P. gingivalis. 
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Gingipain activity 
Trypsin-like activity of P. gingivalis strain A7436 treated with differing concentrations of 
DKPs, cyclo(Leu-Pro) and cyclo(Phe-Pro), after 4 hours of treatment is shown in Figure 3. The 
two cyclopeptides seemed not to enhance or inhibit the virulence factor production compared to 
the control (P. gingivalis alone). The vehicle showed higher but not statistically significant 
inhibition of this enzymatic activity (ANCOVA p≤0.05).   
THP-1 cells viability and number 
 Our results demonstrated that Cyclo(Leu-Pro) had no statistically significant effect on 
cell viability at any of the concentrations tested both alone or upon LPS treatment (ANOVA 
p≤0.05), in fact the viability was between 81-97% for all the groups (Figure 4). Our results also 
showed that cyclo(Leu-Pro) alone did not significantly alter the number of cells (p=0.2) if 
compared to baseline (500000 cells per well), but it seemed to inhibit cell replication at higher 
doses. LPS significantly altered the cell number at 3000ng/mL when combined with DKP, as 
expected (p=0.09 and p=0.018, general linear models) (Figure 5). There was a non-significant 
trend for slightly lower cell numbers when DKPs were present, but it was not a large effect.  
IL-1β change 
 Using real time PCR we observed that the IL-1β mRNA expression indicates that DKP at 
10 ng/ml and 100 ng/ml inhibited the inflammatory response of THP-1 cells upon LPS [300 
ng/ml] treatment (Figure 6) (ANOVA p≤0.05). When LPS was absent THP-1 cells, as expected, 
did not show a high IL-1β mRNA expression, but also in this case cyclo(Leu-Pro) showed to 
have an inhibitory effect (not statistically significant). 
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Discussion 
 Biofilms are structured microbial communities, where microorganisms are embedded in 
extracellular matrix, formed when bacteria adhere to inert or living surfaces. They are found in 
several chronic diseases such as periodontal disease 37.  Within the biofilm, bacteria are protected 
against toxic agents and shear forces and can survive and grow in a hostile environment; they 
also can produce pathogenic factors. It has also been reported that microorganisms that grow in a 
biofilm are much more resistant to antibiotics than planktonic cells 22. Within, and in order to 
build this organized structure, bacteria communicate with each other, through a phenomenon 
known as QS, that is based on small, water-soluble molecules, which act as auto-inducers 22, 38. A 
number of reports suggested that DKPs could comprise a novel family of signaling compounds, 
but some of them were conflicting. Their potential to act as auto-inducer antagonists, preventing 
bacterial biofilm formation has been described. However, to date the precise role played by 
DKPs in bacterial cell-to-cell communication still remains not fully established and speculative 
38-40. Certain 2,5-diketopiperazines have been isolated from bacteria and reported to activate or 
inhibit LuxR-type proteins in AHL biosensor strains, albeit at significantly higher concentrations 
(up to 106 times higher) than native lactones 14, 25-27, 39, 40. Holden et al. in 1999 showed that 
several Gram-negative bacteria produced and secreted cyclic dipeptides with the ability to 
activate and/or antagonize different LuxR-based QS systems. They reported that cyclo(L-Pro-L-
Val) could activate violacein production in the mutant strain of Chromobacterium violaceum and 
cyclo(Phe-Pro) could induce bioluminescence in E.coli 25. Degrassi et al. in 2002 reported that 
Pseudomonas putida WCS358 could produce and secrete four cyclic dipeptides, and some of 
these cyclic dipeptides interacted with the QS LuxI and LuxR homologues 26. Park et al. in 2006 
showed that cyclo(Phe-Pro) produced by V. cholera inhibited the production of the virulence 
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factors, cholera toxin and toxin-coregulated pilus, by activating the expression of a LysR-family 
regulator, and thus down-regulating the expression of ToxRregulon 27. Also Bina et al. in 2013 
confirmed these results 41. Moreover, Li et al. in 2011 showed that the human vaginal isolate 
Lactobacillus reuteri RC-14 produces cyclo(Phe-Pro) and cyclo(Tyr-Pro) that are able to 
interfere with the staphylococcal agr QS system, a key regulator of virulence genes, and repress 
the expression of toxic shock syndrome toxin-1 in Staphylococcus aureus MN8, a prototype of 
toxic shock syndrome S. aureus strains 42. These reports have prompted the proposal that DKPs 
represent a new class of QS signals and potentially even interspecies or interkingdom signals 43-
46. Campbell et al. in 2009 described and screened a library of synthetic DKPs, along with 
several previously reported natural DKPs, to determine the structural features necessary for 
LuxR-type protein activation and inhibition and probe their mechanisms of action. These DKPs, 
using lower concentrations than previous studies, were screened in bacterial reporter gene assays 
14. In contrast to earlier reports 25-27, the native DKPs failed to exhibit either antagonistic or 
agonistic activities in these assays testing the same biosensor strains 14. However, non-natural 
halogenated cyclo(L-Pro-L-Phe) derivatives were capable of inhibiting luminescence in Vibrio 
fischeri. Interestingly, additional experiments revealed that these DKPs do not compete with the 
natural lactone signal, N-(3-oxo-hexanoyl)-L-homoserine lactone, to inhibit luminescence. 
Together, their data suggested that DKPs are not QS signals within the bacteria examined in their 
study. The authors concluded that although these compounds can influence QS-regulated 
outcomes, it seems that they do not do so through direct interaction with LuxR-type proteins and 
therefore their mechanisms of action and physiological relevance remain unknown 14. 
Other studies on food microbiology seem to support the possible role of DKPs as QS 
molecules in food spoilage 10. Gu et al. in 2013 isolated and characterized four DKPs, that 
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function as QS signal molecules, from the extracellular metabolites of Shewanella baltica, the 
specific spoilage organism of Pseudosciaena crocea during 4 °C storage. By supplementation of 
four synthesized DKPs, the spoilage capability of Shewanella baltica was significantly enhanced 
11.  
Kim et al. in 2013 studied the effect of cyclo(L-Phe-L-Pro) on the expression of the total 
mRNA in V. vulnificus, using next-generation sequencing. They reported that the genes most 
highly induced by cyclo(L-Phe-L-Pro) comprised those associated with the transport and 
metabolism of inorganic molecules, particularly iron. The genes negatively regulated included 
those associated with energy production and conversion, as well as carbohydrate metabolism. 
Noticeably, numerous genes related with biofilm formation were modulated by cyclo(L-Phe-L-
Pro) 47.  In our study we did not find an effect of cyclo(Phe-Pro) and cyclo(Leu-Pro) on the 
production of the virulence factor gingipain by P. gingivalis. Nevertheless, these molecules 
could be implicated in the enhancement or inhibition of other virulence factors produced by P. 
gingivalis or other periodontopathogens and this is worthy of further investigation. 
We also showed minimal influence on P. gingivalis growth, but in the literature 
antibacterial action for DKPs containing of leucine-proline or phenylalanine-proline, considering 
the different stereoisomers, has been described. Organic extracts from cultures of the marine 
bacterium Bacillus pumilis furnished inhibitory fractions against Mycobacterium marinum, a 
genetically similar experimental model for M. tuberculosis. Among the active compounds 
isolated and identified was the diketopiperazine of leucine and proline 38. Cultures of two marine 
bacterial strains led to the first reported isolation, as natural products, of a series of DD-DKPs 
containing proline, such as cyclo (D-Pro-D-Leu), and established them as potent inhibitors of the 
pathogenic marine bacterium Vibrio anguillarum 48. Cyclo(L-Leu-L-Pro), also called gancidin 
  
 
37 
W, isolated from two Streptomyces species, was shown to inhibit the growth of vancomycin-
resistant enterococci (VRE)-resistant Enterococcus faecalis strains and to have cytostatic activity 
against leukemic cell lines at the studied concentrations 49, 50. Cyclo(L-Leu-L-Pro), cyclo(L-Phe-
L-Pro), cyclo(L-Leu-L-trans-4-OH-Pro), and cyclo(L-Phe-L-trans-4-OH-Pro) retrieved from the 
fermentation broth of an Aspergillus fumigatus isolate from soil were described as weakly 
antibacterial inhibiting the growth of Staphylococcus aureus and Micrococcus luteus 51. Cyclo(L-
Phe-L-Pro), from a Psychrobacter species showed a protective effect against Vibrio vulnificus 
and induced cytotoxicity in human intestinal epithelial cells 52. Brack et al. in 2014 showed that 
several DKPs produced by Bacillus pumilus induced growth inhibition of pregrown bacteria, 
including gram-positive Staphylococcus aureus, Micrococcus luteus, Bacillus subtilis, and A. 
citreus. They also showed that the soil bacteria Bacillus pumilis produces cyclo(Leu-Pro) and 
cyclo(Phe-Pro) during bacteriolysis of Arthrobacter citreus 53. One of the limitations in 
considering these studies for comparison is that different stereoisomers could have distinct 
activities, indeed some studies revealed that at least one D-amino acid was required for 
antibacterial activity 54. 
Future investigations could include studying the combination of the two DKPs on 
P.gingivalis growth. Indeed, Rhee in 2004 showed the combined synergistic effects of cyclo(L-
leucyl-L-prolyl) and cyclo(L-phenylalanyl-L-prolyl) in inhibiting the growth of VRE and 
pathogenic yeasts (Enterococcus faecium, Enterococcus faecalis strains, Escherichia coli, 
Staphylococcus aureus, Micrococcus luteus, Candida albicans and Cryptococcus neoformans) 55. 
Also Kumar et al. in 2012 described the synergistic inhibitory effects of DKPs cyclo-(L-Pro-L-
Leu), cyclo-(D-Pro-L-Leu), and cyclo-(D-Pro-L-Tyr) in the growth of Bacillus subtilis MTCC 
2756, Staphylococcus aureus MTCC 902, Escherichia coli MTCC 2622 and Pseudomonas 
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aeruginosa MTCC 2642 56. It is noteworthy that Gowrishankar et al. in 2014 reported the 
inhibitory efficacy of cyclo(L-leucyl-L-prolyl) from mangrove rhizosphere bacterium, Bacillus 
amyloliquefaciens (MMS-50) toward cariogenic properties of Streptococcus mutans in vitro 57. 
The same group reported on the combination of these and other DKPs with conventional 
antibiotics showing promising results 58, 59. 
In this investigation cyclo(Leu-Pro) did not show to be toxic to monocytic THP-1 cells, 
indeed it did not affect cell viability (Figure 4) but it demonstrated at higher concentrations to 
inhibit cell replication (Figure 5). On the contrary, two DKPs from marine fungi, from mud 
origin, Prenylcyclotryprostatin B and 9-hydroxyfumitremorgin C, isolated from Aspergillus 
fumigatus, were shown to be moderate inhibitors of human leukemic monocyte lymphoma 
(U937) cells 60.  
We also confirmed that cyclo(Leu-Pro) inhibited monocytic THP-1 expression of IL-1β 
upon LPS stimulation. This preliminary result suggests that DKPs expressed by bacteria could be 
inhibiting a host response in order to survive. In support of these results Bellezza et al. in 2014 
showed that cyclo(Hys-Pro) in the CNS, by acting on the glial cells (macrophage of the CNS), 
intervenes in the crosstalk between nuclear factor-like 2 (Nrf2) and nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-kB) signaling, enhancing antioxidant protection while 
depressing the proinflammatory response, thus resulting in neuronal protection 21. Conversely 
some studies have indicated that linear peptides stimulate production of cytokines in human 
monocytes, T cells, and rat spleen cells 61, 62. Chen et al. in 2012 studied the effect of 5 natural 
DKPs, firstly isolated from the sponge Callyspongia sp., on the release of four cytokines 
[interferon-γ (IFN-γ), pro-inflammatory (TNF-α), anti-inflammatory cytokine (interleukin-10, 
IL-10), and chemokine (monocyte chemoattractant protein-1, (MCP-1)] in murine macrophage-
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like cell line J774A.1 after stimulation in vitro. Results suggested that these five DKPs, 
especially DKP 1 bearing 3-hydroxyl-L-proline (L-Hyp), might be useful as a mild macrophage 
cytokines stimulator 33. Kim et al. in 2015 showed that cyclo(Phe-Pro) suppressed the production 
of proinflammatory cytokines (TNF-α, IL-6, or IL-1β), nitric oxide, and reactive oxygen species 
in a LPS-stimulated monocyte/macrophage cell line and in bone marrow-derived macrophages. 
Specifically, cyclo(Phe-Pro) inhibited inhibitory kB(IkB) kinase (IKK) phosphorylation, IkBα 
degradation, and NF-kB translocation to the cell nucleus, indicating that this cyclopeptide affects 
the NF-kB pathway. Cyclo(Phe-Pro)  did not show a significant level of cytotoxicity in the range 
of 0 to 10 mM 63.  
An alternate hypothesis that could explain the association found between Synergistetes 
and cyclo(Leu-Pro) and cyclo(Phe-Pro) could be that these bacteria are the target of these 
molecules . Cyclopeptides may also cause damage to the host cells directly and this one could be 
another mechanism used by pathogenic bacteria. Indeed, gene expression analysis of mammalian 
cells (INT-407 cell, U2OS cells and Huh7) treated with cyclo(Phe-Pro) revealed that a subset of 
genes related to regulation of reactive oxygen species (ROS) scavenging and production is 
suppressed by the treatment with DKPs. It was found that cyclo(Phe-Pro) induces perturbation of 
the mitochondrial membrane, resulting in increased ROS, especially superoxide, production. 
This finding may help explain some of the roles these cyclopeptides have in the deep periodontal 
pocket 64.   
 This study has several limitations such as the high non-physiological concentrations, of 
cyclopeptides that were used as well as the effect on gingipain showed by the vehicle alone.  
Future directions could be to use lower concentrations of these cyclopeptides and to assess their 
effect on other periodontal bacteria and the expression of other inflammatory-related cytokines.   
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If DKPs will be shown to have a role in the oral biofilm and to enhance its formation and the 
production of virulence factors from the periodontal pathogens, they could represent a suitable 
target for new drugs that could result in a shift in the biofilm composition to create a more 
favorable, steady-state healthy environment.  
 In conclusion, we have confirmed that both DKPs, cyclo(Leu-Pro) and cyclo(Phe-Pro)  
have minimal effects on the growth of P. gingivalis and in the production of gingipain during 
early stationary phase. DKP cyclo(Leu-Pro) does not appear to be toxic to THP-1 cells upon LPS 
challenge but seems to inhibit cell replication in 24 hours treatment. Cyclo(Leu-Pro) showed 
inhibition of the expression of IL-1β, possibly suggesting that DKPs expressed by bacteria could 
be inhibiting a host response in order to survive. Further studies are needed to elucidate the role 
of these molecules in the oral biofilm and their association with Synergistetes.  
If a role in QS is eventually confirmed, drugs directed toward these molecules could play 
a major role in controlling microbial gene expression related to human infection, possibly 
leading to prevention of periodontal infection and biofilm formation.  
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Figure 1. Effect of different concentrations of cyclo(Phe-Pro) on the growth of 
Porphyromonas gingivalis  
 
  
 
 
 
Cyclo(Phe-Pro) seems not to inhibit the growth of Porphyromonas gingivalis (Pg) compared to 
the vehicle alone. No statistically significant difference was found among the three different 
concentrations of cyclo(Phe-Pro) (ANCOVA, p≤0.05). 
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Figure 2. Effect of different concentrations of cyclo(Leu-Pro) on the growth of 
Porphyromonas gingivalis t.  
 
 
 
Cyclo(Leu-Pro) seems not to inhibit the growth of Porphyromonas gingivalis compared to the 
vehicle alone. No statistically significant difference was found among the three different 
concentrations of cyclo(Leu-Pro) (ANCOVA, p≤0.05). 
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Figure 3. Trypsin-like activity of Porphyromonas gingivalis A7436 treated with differing 
concentrations of diketopiperazines [cyclo(Leu-Pro) and cyclo(Phe-Pro)] after 4 hours of 
treatment. 
 
The two cyclopeptides seemed not to enhance or inhibit this enzymatic activity if compared to 
the control (P. gingivalis alone). The vehicle showed higher but not statistically significant 
inhibition (ANCOVA, p≤0.05).   
 
Figure 4.  Monocytic cell viability (%) upon LPS and DKP cyclo(Leu-Pro) treatments.  
 
 
Cyclo(Leu-Pro) had no statistically significant effect on cell viability at any of the concentrations 
tested both alone or upon LPS treatment (ANOVA, p≤0.05). 
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Figure 5.  Monocytic cell growth/survival upon LPS and DKP cyclo (leu-pro) treatments.  
 
Cyclo(Leu-Pro) had no statistically significant effect on cell numbers (p=0.2), but LPS treatment 
with cyclo(Leu-Pro) significantly diminished the cell number (p=0.01) (ANOVA, p≤0.05*). The 
yellow dashed line indicates the baseline number of cells (500000 cells/well).  
 
Figure 6. Monocytic cell inflammatory response upon LPS and DKP cyclo (leu-pro) 
treatments. 
 
 
Cyclo(Leu-Pro) greatly reduced the mRNA expression of IL-1β induced by LPS treatment of 
THP-1 cells (ANOVA, p≤0.05). 
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